MREO Mereo BioPharma Group plc
$0.28▲ +14.47%
Healthcare
Other
After hours
$0.28▲ +0.00%
Sep 11, 7:53 PM ET
Volume 5.06M
Avg Volume (10D) 1.33M
Key Metrics & Fundamentals
Market Cap
$44.71M
P/E Ratio
–
Div Yield
–%
52W Range
0.20 - 2.37
% vs 50 MA
-6.17%
% vs 200 MA
-48.34%
RSI-14
50.3
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.58
Free Cash Flow
-$6.04M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$6.33M
COGS
$0
Operating Exp
$6.91M
Operating Income
-$6.91M
EBIT
-$6.91M
Pretax Income
-$7.01M
Net Income
-$7.01M
EPS (Diluted)
-0.05
Price & Volume History
Loading chart…
Recent News
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
MT Newswires · Sep 11, 2026 3:13 PM
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
MT Newswires · Sep 9, 2026 3:30 PM
European Equities Traded in the US as American Depositary Receipts Marginally Higher in Friday Trading
MT Newswires · Sep 4, 2026 3:05 PM
European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading
MT Newswires · Sep 2, 2026 3:13 PM
European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading
MT Newswires · Sep 1, 2026 3:10 PM
European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading
MT Newswires · Aug 31, 2026 3:12 PM
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
MT Newswires · Aug 20, 2026 3:17 PM
European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading
MT Newswires · Aug 18, 2026 3:13 PM
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading
MT Newswires · Aug 17, 2026 3:12 PM
European Equities Traded in the US Rise in Thursday Trading
MT Newswires · Aug 13, 2026 3:14 PM
Financial Overview - Income Statement
Quarterly
Jun 2025
See MREO's money flow as a full page
Social Sentiment
No Reddit posts found for MREO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.